Literature DB >> 21538056

Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.

Jen-Kou Lin1, Chun-Chi Lin, Shung-Haur Yang, Huann-Sheng Wang, Jeng-Kai Jiang, Yuan-Tzu Lan, Tzu-Chen Lin, Anna Fen-Yau Li, Wei-Shone Chen, Shih-Ching Chang.   

Abstract

PURPOSE: Carcinoembryonic antigen (CEA) measurements performed preoperatively and during the early postoperative period were examined prospectively to assess their prognostic value for colorectal cancer (CRC) patients receiving curative surgery.
METHODS: Between 2000 and 2004, 1,361 patients with CRC who underwent curative surgery at the Taipei Veterans General Hospital were enrolled prospectively. CEA was measured prior to surgery and during the third or fourth postoperative week. The endpoint was length of postoperative disease-free survival, and prognostic importance was determined using the log-rank test and Cox regression hazard model.
RESULTS: Six hundred (44.1%) CRC patients had high CEA concentrations preoperatively, and 188 (13.8%) patients retained high values postoperatively. Within the median follow-up period of 61 (6-108) months, CRC recurred in 313 patients. By univariate analysis TNM staging, tumor differentiation, lymphovascular invasion, preoperative CEA concentration, and postoperative CEA concentration affected the outcome. By multivariate analysis, the prognostic importance of postoperative CEA was retained (95% CI, 1.73-3.01; HR = 2.28) but that of preoperative CEA was lost (95% CI, 0.82-1.33; HR = 1.05). CRC recurred earlier in patients with high postoperative CEA concentrations; metastasis to the liver was common (72.3%) among patients in this group.
CONCLUSIONS: Early postoperative CEA concentration is an independent prognostic factor for CRC. Patients with high postoperative CEA values should receive aggressive follow-up examinations for early relapse of CRC, with special attention paid to recurrence at the liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538056     DOI: 10.1007/s00384-011-1209-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  20 in total

1.  The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer.

Authors:  A M Kaiser; J-C Kang; L S Chan; R W Beart
Journal:  Colorectal Dis       Date:  2006-10       Impact factor: 3.788

2.  Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.

Authors:  J S Choi; J S Min
Journal:  Yonsei Med J       Date:  1997-02       Impact factor: 2.759

3.  Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.

Authors:  Jung Wook Huh; Byung Ryul Oh; Hyeong Rok Kim; Young Jin Kim
Journal:  J Surg Oncol       Date:  2010-04-01       Impact factor: 3.454

Review 4.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

5.  Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

Authors:  Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2005-10-31       Impact factor: 44.544

6.  Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.

Authors:  Yoon-Ah Park; Kang Young Lee; Nam Kyu Kim; Seung Hyuk Baik; Seung Kook Sohn; Chang Whan Cho
Journal:  Ann Surg Oncol       Date:  2006-03-13       Impact factor: 5.344

7.  Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.

Authors:  J Y Wang; C Y Lu; K S Chu; C J Ma; D C Wu; H L Tsai; F J Yu; J S Hsieh
Journal:  Eur Surg Res       Date:  2007-04-23       Impact factor: 1.745

8.  Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Authors:  Ryo Takagawa; Syoichi Fujii; Mitsuyoshi Ohta; Yasuhiko Nagano; Chikara Kunisaki; Shigeru Yamagishi; Shunichi Osada; Yasushi Ichikawa; Hiroshi Shimada
Journal:  Ann Surg Oncol       Date:  2008-10-10       Impact factor: 5.344

Review 9.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Authors:  M J Duffy; A van Dalen; C Haglund; L Hansson; E Holinski-Feder; R Klapdor; R Lamerz; P Peltomaki; C Sturgeon; O Topolcan
Journal:  Eur J Cancer       Date:  2007-05-18       Impact factor: 9.162

10.  Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels.

Authors:  Jeong Yeon Kim; Nam Kyu Kim; Seung Kook Sohn; Yong Wan Kim; Kim Jin Soo Kim; Hyuk Hur; Byung Soh Min; Chang Hwan Cho
Journal:  Ann Surg Oncol       Date:  2009-08-06       Impact factor: 5.344

View more
  40 in total

1.  Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.

Authors:  Soo Young Lee; Jeong Seon Jo; Hun Jin Kim; Chang Hyun Kim; Jae-Kyun Ju; Young Jin Kim; Hyeong Rok Kim
Journal:  Int J Colorectal Dis       Date:  2014-11-01       Impact factor: 2.571

2.  Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.

Authors:  Giovanni Li Destri; Antonio Salvatore Rubino; Rosalia Latino; Fabio Giannone; Raffaele Lanteri; Beniamino Scilletta; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-04

3.  Serum GROβ: a potential tumor-associated biomarker for colorectal cancer.

Authors:  Zhaoxu Zheng; Min Zheng; Jianjun Bi; Qiang Feng; Zhigang Yue; Yanqiu Zhou; Wanning Hu; Haizeng Zhang; Hongjun Gao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.

Authors:  Pei-Ching Lin; Jen-Kou Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Anna Fen-Yau Li; Wei-Shone Chen; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2012-03-20       Impact factor: 2.571

5.  Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer.

Authors:  Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Kenji Matsuda; Yoshimasa Oku; Toru Nasu; Junji Ieda; Naoyuki Yamamoto; Hiromitsu Iwamoto; Yoh Takei; Yuki Mizumoto; Hiroki Yamaue
Journal:  Surg Today       Date:  2014-02-07       Impact factor: 2.549

6.  Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis.

Authors:  Songmi Jeong; Taek Keun Nam; Jae Uk Jeong; Sung Hwan Kim; Kyubo Kim; Hong Seok Jang; Bae Kwon Jeong; Jong Hoon Lee
Journal:  Clin Exp Metastasis       Date:  2016-08-23       Impact factor: 5.150

7.  The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR-TKIs but is not an indication of acquired resistance to EGFR-TKIs in NSCLC patients with EGFR mutationsm.

Authors:  Jingquan Han; Yuzhang Li; Shouqiang Cao; Qing Dong; Guibin Zhao; Xiangyu Zhang; Jian Cui
Journal:  Biomed Rep       Date:  2017-05-19

8.  Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis.

Authors:  Ignazio Tarantino; Rene Warschkow; Bruno M Schmied; Ulrich Güller; Markus Mieth; Thomas Cerny; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2016-04-11       Impact factor: 3.452

Review 9.  Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Authors:  Enikő Orosz; István Ember; Katalin Gombos; László Tóth; Ádám Tarpay; Ákos Pap; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2013-07-19       Impact factor: 3.201

10.  Survival in Resected Stage II Colorectal Cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative CEA Level, and The Number of Examined Lymph Nodes.

Authors:  Hsiang-Lin Tsai; Ching-Wen Huang; Chao-Wen Chen; Yung-Sung Yeh; Cheng-Jen Ma; Jaw-Yuan Wang
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.